Search results for “Trastuzumab” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 833 patents, we discovered top 163 key players by total patent application. Genentech, Inc., F. Hoffmann-La Roche Ltd., Seagen Inc. are dominant in this area. They take 46.10% of the total patent filing.
Genentech, Inc.
California, United States
Patent: 183
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 181
Seagen Inc.
Washington, United States
Patent: 20
ZymoGenetics, Inc.
Washington, United States
Patent: 20
Pharmacia & Upjohn Co. LLC
Michigan, United States
Patent: 20
Pharmacia Italia Spa
MILAN, Italy
Patent: 19
Pierre Fabre Médicament SAS
France
Patent: 19
AbClon, Inc.
South Korea
Patent: 17
Wellstat Biologics Corp.
United States
Patent: 15
Novartis AG
Basel-Stadt, Switzerland
Patent: 13
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 17 patents, we discovered top 3 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 15
STARTUP
Biomunex Pharmaceuticals
France
Patent: 6
STARTUP
Biosion, Inc.
Jiangsu Sheng, China
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 191 patents applied in the last 5 years. We discover 65 most active companies in this area. The fast-growing Genentech, Inc., F. Hoffmann-La Roche Ltd., Seagen Inc. take 61.78% of patent filing during this period.
Genentech, Inc.
California, United States
Patent: 55
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 43
Seagen Inc.
Washington, United States
Patent: 20
Ambrx, Inc.
California, United States
Patent: 6
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 6
OncoPlex Diagnostics, Inc.
United States
Patent: 5
Japanese Foundation for Cancer Research
Tokyo-to, Japan
Patent: 5
SLSG Ltd. LLC
Delaware, United States
Patent: 5
Toyo Kohan Co., Ltd.
Tokyo-to, Japan
Patent: 5
Sutro Biopharma, Inc.
California, United States
Patent: 5
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 191 patents in last 5 years, we discover 51 new entrants. Seagen Inc., Ambrx, Inc., Memorial Sloan-Kettering Cancer Center are the most active new entrants in this area.
Seagen Inc.
Washington, United States
Patent: 20
Ambrx, Inc.
California, United States
Patent: 6
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 6
Japanese Foundation for Cancer Research
Tokyo-to, Japan
Patent: 5
SLSG Ltd. LLC
Delaware, United States
Patent: 5
Toyo Kohan Co., Ltd.
Tokyo-to, Japan
Patent: 5
Sutro Biopharma, Inc.
California, United States
Patent: 5
Peking University
Beijing Shi, China
Patent: 4
Zydus Lifesciences Ltd.
Gujarat, India
Patent: 4
Beijing Zeqin Biomedicine Co., Ltd.
Beijing Shi, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 147 patents, we discovered top 29 universities and scientific research institutions by total patent application. National University of Singapore, Kyoto University, Tohoku University are dominant in this area. They take 27.21% of the total patent filing.
National University of Singapore
Central Region, Singapore
Patent: 6
Kyoto University
Kyoto-fu, Japan
Patent: 6
Tohoku University
Miyagi-ken, Japan
Patent: 6
University of South Florida
United States
Patent: 5
Yale University
Connecticut, United States
Patent: 4
Peking University
Beijing Shi, China
Patent: 4
University of Lodz
Poland
Patent: 3
The Second Military Medical University
Shanghai Shi, China
Patent: 3
American University of Sharjah
United Arab Emirates
Patent: 2
South China Normal University
Guangdong Sheng, China
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: